Reporte zur Charge FW0698

Symptomtext

Tested positive; Tested positive; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from product quality group. A 17-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 19Mar2021 as dose 1, single (Lot number: EP6955), in left arm, on 09Apr2021 as dose 2, single (Lot number: EP6955), in left arm and on 03Feb2022 at 17:00 as dose 3 (booster), single (Lot number: FW0698) at the age of 16 years, in left arm, all intramuscular for covid-19 immunisation. The patient had no relevant medical history. There were no concomitant medications. Patient did not received any other vaccine in four weeks and not received any other medications in two weeks. Patient had no known allergies. The following information was reported: VACCINATION FAILURE (medically significant) with onset 05Apr2022, outcome "unknown", COVID-19 (medically significant) with onset 05Apr2022, outcome "recovering" and all described as "Tested positive". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (05Apr2022) Positive, notes: Nasal Swab. Therapeutic measures were not taken as a result of vaccination failure, covid-19. Patient did not received any other vaccine in four weeks and not received any other medications in two weeks. AE resulted was in none of the above. She did not experienced Covid prior vaccination. She was tested Covid post vaccination. No follow-up attempts are possible. No further information is expected.